Bradley N. Mills

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. David C. Linehan · 8 shared papers, 2020–2026 · strength 1.28
   • Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
   • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
2. Joseph D. Murphy · 6 shared papers, 2020–2026 · strength 0.87
   • Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
3. Jian Ye · 5 shared papers, 2020–2026 · strength 0.81
   • Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
4. Angela L. Hughson · 4 shared papers, 2024–2026 · strength 0.80
   • Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
   • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
5. Scott A. Gerber · 5 shared papers, 2020–2025 · strength 0.77
   • Paper Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (M… DOI 10.1021/acsomega.2c07080↗
   • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
6. Scott A. Gerber · 4 shared papers, 2022–2026 · strength 0.72
   • Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
7. Tara G Vrooman · 4 shared papers, 2022–2025 · strength 0.70
   • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
8. Haoming Qiu · 3 shared papers, 2022–2026 · strength 0.53
   • Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
   • Paper Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. DOI 10.1158/1078-0432.ccr-21-2495↗
9. Laura Maria Calvi · 2 shared papers, 2024–2025 · strength 0.35
   • Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
   • Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
10. Booyeon Julia Han · 3 shared papers, 2020–2022 · strength 0.34
    • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
    • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
    • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
11. Jian Ye · 2 shared papers, 2020–2025 · strength 0.32
    • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
    • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
12. Debamitra Chakraborty · 1 shared paper, 2023 · strength 0.22
    • Paper Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (M… DOI 10.1021/acsomega.2c07080↗
13. Roman Sobolewski · 1 shared paper, 2023 · strength 0.22
    • Paper Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (M… DOI 10.1021/acsomega.2c07080↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.